Commenting on Zerhouni Commenting on the NIH Funding Decline

Since we had an interesting discussion here back in September about the rapid decline in success rates of NIH R01 grants, I should point readers over to Effect Measure for some informed commentary on a recent article in Science (subscription required) from NIH Director Elias A. Zerhouni. The success rate of Type-1 grants, for example, fell by more than one half from 2000 to 2005, a bad sign coming from the nation's flagship biomedical research grant program. Certainly, then, Zerhouni has some 'splainin' to do. I'll defer to Effect Measure, though, to summarize and comment on Zerhouni's argument

One thing I will add, though, is that while the drop in success rates cannot be solely blamed on the Bush Administration or the Republican Congress, both have been shockingly silent and inactive on the issue, allowing the slide to continue. Hopefully we can expect better from the incoming Democratic Congress.

More like this

In a letter in last week's issue of Science (subscription required), two scientists from the National Caucus of Basic Biomedical Science Chairs--H. George Mandel and Elliot S. Vesell--describe in detail the funding crisis currently plaguing American scientists. The authors demonstrate a shocking…
Since I reported yesterday on a letter in Science describing the current decline in funding of NIH (National Institutes of Health) R01 grants, several others have chimed in as well. PZ Myers of Pharyngula gave the post a mention, and Mike the Mad Biologist as well as Orac of Respectful Insolence…
I was going to blog about this a couple of days ago, but the Scientific Activist beat me to it, leading to a heads-up from PZ Myers. Never let it be said that a little thing like that stopped me from putting my two cents in. Besides, I think I bring a certain perspective that hasn't been addressed…
by revere [Since my colleague and new blog sibling Dave Ozonoff posted here some advice on NIH grant writing in response to a post of mine over at Effect Measure, I thought I'd cross-post a follow-up I did on NIH funding a few days later. BTW, Dave, I'll have to give you some lessons in snarkiness…